With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.50777-76-9,2-(Diphenylphosphino)benzaldehyde,as a common compound, the synthetic route is as follows.
General procedure: To a solution of 12 (mu-SCH2CH2CH2S-mu)Fe2(CO)6 (0.193g, 0.5mmol) and 13 2-(diphenylphosphino)benzaldehyde (0.145g, 0.5mmol) in 14 CH2Cl2 (20mL) was added a solution of 15 Me3NO¡¤2H2O (0.056g, 0.5mmol) in 16 MeCN (10mL). The mixture was stirred at room temperature for 1h and then the solvent was reduced on a rotary evaporator and the residue was subjected to TLC separation using CH2Cl2/17 petroleum ether=1:1 (v/v) as eluent.
#N/A
Reference£º
Article; Sheng, Yu-Dong; Yu, Xiao-Yong; Liu, Xu-Feng; Li, Yu-Long; Polyhedron; vol. 137; (2017); p. 134 – 139;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate